HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator

Executive Summary

Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.

You may also be interested in...



Vitamin C COVID-19 'Cure' Claims Not Getting Past ASA

UK advertising watchdog ASA reprimands Revival Drinks for social media posts which claimed its vitamin C supplement could cure COVID-19.

COVID-19 Claims for OTC Intravenous Drips Found In Advertising On Both Sides Of Atlantic

UK agency advises two medical spas to discontinue claims suggesting IV drips prevent or cure COVID-19. In separate rulings to the companies, ASA notes the UK MHRA says including COVID-19 in promotions would bring the IV drips under medicines regulation.

UK Industry Welcomes Coronavirus Responsible Advertising Guidelines

UK industry association, PAGB, welcomes a clarification from the country's advertising standards authority on how consumer healthcare products should be advertised during the Covid-19 pandemic.

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel